Gene · 2588
Papers3,532
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,532
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The novel linkage between Fuz and Gpr161 genes regulates sonic hedgehog signaling during mouse embryonic development. | bioRxiv | 2024 | 38260275 | PubTator, text mining | PubMed |
| Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy. | Int J Mol Sci | 2024 | 38256186 | PubTator, text mining | PubMed |
| Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases. | Biology (Basel) | 2024 | 38248465 | PubTator, text mining | PubMed |
| Gas Plasma Exposure Alters Microcirculation and Inflammation during Wound Healing in a Diabetic Mouse Model. | Antioxidants (Basel) | 2024 | 38247492 | PubTator, text mining | PubMed |
| Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain. | Acta Pharm Sin B | 2024 | 38239234 | PubTator, text mining | PubMed |
| The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway. | Cell Death Dis | 2024 | 38238314 | PubTator, text mining | PubMed |
| Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization. | Cell Commun Signal | 2024 | 38233929 | PubTator, text mining | PubMed |
| cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment. | J Hematol Oncol | 2024 | 38233872 | PubTator, text mining | PubMed |
| Hepatocyte GPCR signaling regulates IRF3 to control hepatic stellate cell transdifferentiation. | Cell Commun Signal | 2024 | 38233853 | PubTator, text mining | PubMed |
| Alternative splicing of latrophilin-3 controls synapse formation. | Nature | 2024 | 38233523 | PubTator, text mining | PubMed |
| A framework for Frizzled-G protein coupling and implications to the PCP signaling pathways. | Cell Discov | 2024 | 38182578 | PubTator, text mining | PubMed |
| 2,4-disubstituted 6-fluoroquinolines as potent antiplasmodial agents: QSAR, homology modeling, molecular docking and ADMET studies. | J Taibah Univ Med Sci | 2024 | 38179257 | PubTator, text mining | PubMed |
| Nonviral delivery of nCas9 for "safe harbor" integration to treat MPS IVA. | Mol Ther Methods Clin Dev | 2024 | 38178916 | PubTator, text mining | PubMed |
| Molecular basis of human trace amine-associated receptor 1 activation. | Nat Commun | 2024 | 38168118 | PubTator, text mining | PubMed |
| Injectable Radiopaque Hyaluronic Acid Granular Hydrogels for Intervertebral Disc Repair. | Adv Healthc Mater | 2024 | 38142300 | PubTator, text mining | PubMed |
| Eyeless razor clam Sinonovacula constricta discriminates light spectra through opsins to guide Ca2+ and cAMP signaling pathways. | J Biol Chem | 2024 | 38043801 | PubTator, text mining | PubMed |
| Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD-L1 in Cancer Therapy. | Adv Sci (Weinh) | 2024 | 37934012 | PubTator, text mining | PubMed |
| Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct. | Am J Physiol Renal Physiol | 2024 | 37916285 | PubTator, text mining | PubMed |
| Chondroitinase as a therapeutic enzyme: Prospects and challenges. | Enzyme Microb Technol | 2024 | 37898093 | PubTator, text mining | PubMed |
| The deleterious variants of N-acetylgalactosamine-6-sulfatase (GalN6S) enzyme trigger Morquio a syndrome by disrupting protein foldings. | J Biomol Struct Dyn | 2024 | 37222604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2588/papers?page=8